Jeffrey Lee joined Rubius Therapeutics in September 2021 as Head of Intellectual Property. He is an accomplished patent attorney with nearly 15 years of experience in counseling clients on a variety of legal issues ranging from patent prosecution, licensing, freedom-to-operate, due diligence, product development, trade secrets, and patent litigation. Jeff joined Rubius from Sanofi, where he served as Senior Patent Counsel and was responsible for numerous clinical stage assets, primarily focused in the oncology and immunology/inflammation therapeutic areas. Prior to Sanofi, Jeff was an intellectual property litigation associate in the New York offices of Steptoe & Johnson LLP and Mayer Brown LLP, where he worked on several high-profile litigations involving antibody technology. Jeff started his legal career as an intellectual property attorney in the New York office of WilmerHale LLP.
Jeff earned his B.A. in Biochemistry and Classical Studies from the University of Pennsylvania, his Ph.D. in Neurobiology and Anatomy from the University of Utah, and his J.D. from American University Washington College of Law. He is licensed to practice law in New York, New Jersey, and Massachusetts, and is a registered patent attorney with the United States Patent and Trademark Office.